Mark Ball, MD, FACS

1.5K posts

Mark Ball, MD, FACS banner
Mark Ball, MD, FACS

Mark Ball, MD, FACS

@markballmd

Urologic Oncologist at NCI | Assoc Prof & Fellowship APD | #kidneycancer #pheo surgery & translational genomics 🧬 Views mine

Bethesda, MD Katılım Haziran 2010
574 Takip Edilen3K Takipçiler
Mark Ball, MD, FACS
Mark Ball, MD, FACS@markballmd·
NCI Urologic Oncolgy Branch is still accepting @SUO_YUO fellowship applications - interviews April 13, 14, 20. DM or email margot.michels@nih.gov for more information.
English
0
5
14
2.6K
Mark Ball, MD, FACS retweetledi
UroToday.com
UroToday.com@urotoday·
Unraveling smooth muscle-rich #RenalCellCarcinoma: Clinical, oncological, genetic, and pathological insights. #AuthorCommentary Smooth muscle–rich #RCC is a rare but distinct entity. In the largest cohort to date, smrRCC showed frequent bilateral multifocal disease, unique genetic features, and rare metastatic potential—highlighting the need for genetic testing, surveillance, and nephron-sparing care. #ReadMore on UroToday > bit.ly/464Vech @RubenBlachmanMD @MillanBraden @markballmd @theNCI @urogoldjournal
English
0
4
11
1.2K
Mark Ball, MD, FACS
Mark Ball, MD, FACS@markballmd·
A familiar face returns, wiser in years and rich in scholarship. Welcome back @PGomellaMD, to UOB grand rounds on Genetics of Prostate Cancer.
Mark Ball, MD, FACS tweet mediaMark Ball, MD, FACS tweet media
English
0
2
13
2.3K
Mark Ball, MD, FACS retweetledi
UroToday.com
UroToday.com@urotoday·
Unraveling smooth muscle-rich #RenalCellCarcinoma: Clinical, oncological, genetic, and pathological insights. #AuthorCommentary Smooth muscle–rich #RCC is a rare but distinct entity. In the largest cohort to date, smrRCC showed frequent bilateral multifocal disease, unique genetic features, and rare metastatic potential—highlighting the need for genetic testing, surveillance, and nephron-sparing care. #ReadMore on UroToday > bit.ly/464Vech @RubenBlachmanMD @MillanBraden @markballmd @theNCI @urogoldjournal
English
0
1
12
717
Mark Ball, MD, FACS retweetledi
Urologic Oncology
Urologic Oncology@UrolOncol·
The editorial team of Urologic Oncology extends its sincere appreciation to our peer reviewers who have completed over 100 manuscript reviews. Their dedication of time, depth of expertise, and thoughtful insight strengthen the journal’s quality and help advance the field.
Urologic Oncology tweet media
English
0
9
44
9.4K
Mark Ball, MD, FACS retweetledi
BackTable Tumor Board
BackTable Tumor Board@_backtableONC·
Kidney cancer management is evolving. How are experts adapting? In this installment of BackTable Tumor Board, Dr. Brandon Manley, Dr. Raquibul Hannan, and Dr. Rana McKay join guest host Dr. Mark Ball to share their multidisciplinary perspectives on challenging, real-world kidney cancer cases. This podcast is supported by: Ferring Pharmaceuticals Watch the episode here: na2.hubs.ly/H01mb5Q0 #ONC23 #kidneycancer #oncology #urology
English
0
3
7
1.2K
Mark Ball, MD, FACS retweetledi
Ali Sheikhy, MD
Ali Sheikhy, MD@AliSheikhyMD·
MRI features can distinguish benign from malignant HLRCC-associated renal cysts. Our model could spare >50% of patients with benign cysts from unnecessary surgery. Huge thanks to my PI @aamalayeri and our amazing team @aryanzg @NIHClinicalCntr ! rdcu.be/eGH9z
Ali Sheikhy, MD tweet media
English
0
1
14
899
Ashkan Malayeri
Ashkan Malayeri@aamalayeri·
Radiology is humbling. Today is my last day at the NIH. After 9 years of working at the @NIHClinicalCntr, doing almost exclusively research on hereditary renal masses, I reviewed a case of a kidney mass, and I had zero idea what it was. So long @NIH - thanks for the memories!
English
8
5
116
15.8K
Dave Penson
Dave Penson@urogeek·
With all this hubbub about the couple that got busted at the Coldplay concert, I thought I would share with you what I would get in trouble for…
Dave Penson tweet media
English
2
0
28
2.1K